arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Alice Traversa

2 papers · 2025–2026

2025: 12026: 1
2025peak 1 in 20252026

Frequent co-authors

Papers

showing 1–2 of 2 RSS

Variable Intrafamilial Cardiac Phenotype Segregating With a TBX20 Missense Variant in the Putative Transcriptional Activation Domain

Gioia Mastromoro, Alice Traversa, Daniele Guadagnolo +7 more

Artificial Intelligence · IRIS Research product catalog (Sapienza University of Rome) · · cited 0× · OpenAlex ↗ · more like this ·

Non-syndromic atrioventricular canal (AVC) occurs in ∼1/1000 livebirths and most of them are considered sporadic cases or the result of multifactorial inheritance. We report on a fetus diagnosed with non-syndromic AVC, whose mother showed interatrial septal tissue redundancy and slight ascending aortic ectasia. Trio-based exome sequencing (ES), performed during the pregnancy, detected the maternally inherited rare c.946A > G p.(Thr316Ala) missense variant in the TBX20 gene as the reasonable cause of this condition. Segregation analysis extended to the grandmother, previously diagnosed with isolated ascending aortic ectasia, disclosed the presence of the same variant. This is the first case of AVC familial spectrum caused by a TBX20 variant in the putative transcriptional activation domain. Moreover, this case highlights a possible common molecular cause underlying distinct and not…

Vision Transformers for Preoperative CT-Based Prediction of Histopathologic Chemotherapy Response Score in High-Grade Serous Ovarian Carcinoma

Francesca Fati, Felipe Coutinho, Marika Reinius +25 more

cs.CV · · arXiv ↗ · more like this ·

Purpose. High-grade serous ovarian carcinoma (HGSOC) is characterized by pronounced biological and spatial heterogeneity and is frequently diagnosed at an advanced stage. Neoadjuvant chemotherapy (NACT) followed by delayed primary surgery is commonly employed in patients unsuitable for primary cytoreduction. The Chemotherapy Response Score (CRS) is a validated histopathological biomarker of response to NACT, but it is only available postoperatively. In this study, we investigate whether pre-treatment computed tomography (CT) imaging and clinical data can be used to predict CRS as an investigational decision-support adjunct to inform multidisciplinary team (MDT) discussions regarding expected treatment response. Methods. We proposed a 2.5D multimodal deep learning framework that processes lesion-dense omental slices using a pre-trained Vision Transformer encoder and integrates the…